Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
15:30:28 EDT Mon 07 Sep 2026
Enter Symbol
or Name
USA
CA



Q:CRMD - CORMEDIX INC - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CRMD - Q0.17.51·18.100.88.43    13.83  6.125Sep 04Sep 0115 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-09-01 08:30U:CRMDNews ReleaseCorMedix Therapeutics to Participate in the Wells Fargo Healthcare Conference
2026-08-13 07:30U:CRMDNews ReleaseCormedix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
2026-07-29 08:30U:CRMDNews ReleaseCorMedix Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 13, 2026
2026-06-08 08:30U:CRMDNews ReleaseU.S. Court of Appeals for the Federal Circuit Affirms Victory for Cormedix Therapeutics in Minocin(TM) Patent Litigation
2026-05-15 08:30U:CRMDNews ReleaseCormedix Therapeutics to Participate in two Upcoming Investor Conferences
2026-05-14 07:30U:CRMDNews ReleaseCormedix Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
2026-05-05 08:30U:CRMDNews ReleaseCorMedix Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 14, 2026
2026-04-27 07:30U:CRMDNews ReleaseCorMedix Therapeutics Announces Positive Topline Results from Phase III ReSPECT Trial Assessing REZZAYO(TM) for the Prophylaxis of Invasive Fungal Diseases in Allogeneic Hematopoietic Stem Cell Transplantation Patients
2026-04-07 08:30U:CRMDNews ReleaseCorMedix to Participate in Needham Virtual Healthcare Conference
2026-03-05 07:30U:CRMDNews ReleaseCorMedix Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
2026-03-02 08:30U:CRMDNews ReleaseCorMedix Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 5, 2026
2026-02-12 08:30U:CRMDNews ReleaseCorMedix to Participate in Upcoming Investor Conferences
2026-02-02 08:30U:CRMDNews ReleaseCorMedix Therapeutics Announces Share Repurchase Program
2026-01-29 08:30U:CRMDNews ReleaseCorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026
2026-01-09 08:30U:CRMDNews ReleaseCorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
2026-01-08 08:05U:CRMDNews ReleaseCorMedix Therapeutics Announces Leadership and Board Updates
2026-01-08 08:00U:CRMDNews ReleaseCorMedix Therapeutics Announces Preliminary Fourth Quarter and Full Year 2025 Results and Provides Business Updates
2025-12-18 08:00U:CRMDNews ReleaseCorMedix Therapeutics Announces Positive Data From Ongoing Real World Evidence Study of DefenCath
2025-11-12 16:05U:CRMDNews ReleaseTalphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update
2025-11-12 11:01U:CRMDNews ReleaseStrong Earnings and Biotech Resilience Define the Midweek Momentum